p53 in malignant glioma: 20 years later and still much to learn

Journal Title: Neuro-Oncology - Year 2010, Vol 12, Issue 5

Abstract

Authors and Affiliations

C. David James

Keywords

Related Articles

Akt signaling pathway: a target for radiosensitizing human malignant glioma

Radiation therapy plays a central role in the treatment of glioblastoma, but it is not curative due to the high tumor radioresistance. Phosphatidyl-inositol 3-kinase/protein kinase B (Akt) and Janus kinase (JAK)/signal t...

Gliomas display a microRNA expression profile reminiscent of neural precursor cells

Gliomas express many genes that play a role in neural precursor cells (NPCs), but no direct comparison between glioma and stem cell (SC) gene expression profiles has been performed. To investigate the similarities and di...

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

The aim of this clinical trial was to investigate safety and efficacy when combining cetuximab with bevacizumab and irinotecan in patients with recurrent primary glioblastoma multiforme (GBM). Patients were included with...

Human umbilical cord blood stem cells show PDGF-D–dependent glioma cell tropism in vitro and in vivo

Despite advances in clinical therapies and technologies, the prognosis for patients with malignant glioma is poor. Neural stem cells (NSCs) have a chemotactic tropism toward glioma cells. The use of NSCs as carriers of t...

Download PDF file
  • EP ID EP679600
  • DOI  10.1093/neuonc/noq037
  • Views 29
  • Downloads 0

How To Cite

C. David James (2010). p53 in malignant glioma: 20 years later and still much to learn. Neuro-Oncology, 12(5), -. https://europub.co.uk/articles/-A-679600